|
ATCC
primary human lung fibroblasts hlfs ![]() Primary Human Lung Fibroblasts Hlfs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/primary human lung fibroblasts hlfs/product/ATCC Average 99 stars, based on 1 article reviews
primary human lung fibroblasts hlfs - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
ATCC
human keratinocyte ![]() Human Keratinocyte, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human keratinocyte/product/ATCC Average 96 stars, based on 1 article reviews
human keratinocyte - by Bioz Stars,
2026-05
96/100 stars
|
Buy from Supplier |
|
ATCC
pcs 201018 ![]() Pcs 201018, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/pcs 201018/product/ATCC Average 99 stars, based on 1 article reviews
pcs 201018 - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
ATCC
non cancerous healthy hdf cells ![]() Non Cancerous Healthy Hdf Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/non cancerous healthy hdf cells/product/ATCC Average 99 stars, based on 1 article reviews
non cancerous healthy hdf cells - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
ATCC
neonatal human fibroblasts ![]() Neonatal Human Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/neonatal human fibroblasts/product/ATCC Average 99 stars, based on 1 article reviews
neonatal human fibroblasts - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
ATCC
human uterine fibroblasts ![]() Human Uterine Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human uterine fibroblasts/product/ATCC Average 99 stars, based on 1 article reviews
human uterine fibroblasts - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
ATCC
human cardiac fibroblast hcf cells ![]() Human Cardiac Fibroblast Hcf Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human cardiac fibroblast hcf cells/product/ATCC Average 99 stars, based on 1 article reviews
human cardiac fibroblast hcf cells - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
ATCC
human dermal nhd fibroblast cell line ![]() Human Dermal Nhd Fibroblast Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human dermal nhd fibroblast cell line/product/ATCC Average 97 stars, based on 1 article reviews
human dermal nhd fibroblast cell line - by Bioz Stars,
2026-05
97/100 stars
|
Buy from Supplier |
|
PromoCell
normal human dermal fibroblast nhdf ![]() Normal Human Dermal Fibroblast Nhdf, supplied by PromoCell, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/normal human dermal fibroblast nhdf/product/PromoCell Average 98 stars, based on 1 article reviews
normal human dermal fibroblast nhdf - by Bioz Stars,
2026-05
98/100 stars
|
Buy from Supplier |
|
ATCC
normal human fibroblasts ![]() Normal Human Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/normal human fibroblasts/product/ATCC Average 93 stars, based on 1 article reviews
normal human fibroblasts - by Bioz Stars,
2026-05
93/100 stars
|
Buy from Supplier |
|
ATCC
human lung fibroblasts ![]() Human Lung Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human lung fibroblasts/product/ATCC Average 93 stars, based on 1 article reviews
human lung fibroblasts - by Bioz Stars,
2026-05
93/100 stars
|
Buy from Supplier |
|
ATCC
certified primary normal human dermal fibroblasts ![]() Certified Primary Normal Human Dermal Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/certified primary normal human dermal fibroblasts/product/ATCC Average 95 stars, based on 1 article reviews
certified primary normal human dermal fibroblasts - by Bioz Stars,
2026-05
95/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cell Death Discovery
Article Title: Trifluoperazine causes mast cell apoptosis through a secretory granule-mediated pathway
doi: 10.1038/s41420-026-03122-x
Figure Lengend Snippet: A Human lung smooth muscle cells (HLSMCs), lung fibroblasts (HLFs), and small airway epithelial cells (HSAECs) were treated with TFP at the indicated concentrations for 24 h. Human peripheral blood eosinophils and neutrophils were treated with TFP for 2 h. Cell viability was assessed by staining the cells with Annexin V (AnnV) and DRAQ7. Viable cells, AnnV − DRAQ7 − ; apoptotic cells, AnnV + DRAQ7 − ; necrotic/late apoptotic cells, AnnV + DRAQ7 + . HSAECs, n = 6 from three independent experiments; HLSMCs, eosinophils, neutrophils, n = 4 from four independent experiments; HLFs, n = 3 from one individual experiment representative of three independent experiments (One-way ANOVA for HLSMCs, HLFs; Kruskal-Wallis for HSAECs; Friedman test for eosinophils, neutrophils). B – C Bone marrow-derived MCs (BMMCs) and peritoneal cell-derived MCs (PCMCs) treated under the same conditions as in ( A ) for 24 h. BMMCs, n = 5 from two independent experiments; PCMCs, n = 3 from one individual experiment representative of three independent experiments (One-way ANOVA). Untreated (control) cells were used for statistical comparisons to all other groups in all figures. The bar charts show mean values + SEM or median + interquartile range. * P < 0.05; ** P < 0 .01; **** P < 0.0001. D Effect of TFP on DNA degradation. MCs were preincubated with bafilomycin A1 (Baf A1) (20 nM) for 2 h followed by treatment with TFP (10 μΜ) for 2 h. DNA was extracted from MCs and fragmentation was assessed by agarose gel electrophoresis. St standard marker.
Article Snippet:
Techniques: Staining, Derivative Assay, Control, Agarose Gel Electrophoresis, Marker
Journal: Annals of the rheumatic diseases
Article Title: RUNX1 is expressed in a subpopulation of dermal fibroblasts and is associated with disease severity of systemic sclerosis
doi: 10.1016/j.ard.2025.10.033
Figure Lengend Snippet: TGF- β 1 increases the RUNX1 expression in SSc fibroblasts and inhibition of RUNX1 reduces ECM markers. (A) Western blot of 3 isolated fibroblasts lines treated with TGF- β 1. The blot shows all isoforms of RUNX1a, b, and c that are overexpressed under the TGF- β 1 stimulation. (B) Schematic graph illustrating the timeline for the culture and TGF- β 1 treatment of dcSSc-isolated fibroblasts, matched healthy-isolated fibroblasts, and normal human dermal (NHD) fibroblast cells. RUNX1 expression rate in samples treated with TGF- β 1 (in red) vs control (in blue) for the 24 hours after exposure. (C) Volcano plot of differentially expressed analysis of the 2 SSc-isolated fibroblast lines at 12 hours after exposure vs the baseline. (D) The pathway analysis of Reactome gene sets shows the biological pathways and processes that are significantly represented within top DEG genes of SSc-isolated fibroblast lines 12 hours after TGF- β 1 treatment vs the baseline. Data from B to D were obtained through publicly available data of GSE12493 . (E) Schematic graph showing 2 lines of SSc-isolated fibroblasts treated with siRNA against RUNX1 (siRUNX1) and nontargeting control siRNA (siNC). (F) UMAP projection and dot plot of RUNX1 and CBFB of the single-cell RNA-seq data. (G) UMAP of 10 fibroblast clusters (0–9) for siR-UNX1 and siNC. (H) Cell proportion of siRUNX1 and siNC per cluster. (I) Top 4 upregulated and downregulated marker genes per cluster. (J) Top 15 enriched pathways that are significantly represented across siRUNX1 and siNC (K) Bar plots showing the percentage of cells expressing COL1A1, FN1, COL4A1, LUM, ACTA2, LGR5, COL8A1, COMP , and THBS1 per condition (red: siRUNX1, green: siNC) or per cluster. (L) Module score for extracellular matrix organisation pathway per cluster and per condition. (M) Feature plot of the ECM module score. dcSSc, diffuse cutaneous SSc; DEG, differentially expressed gene; ECM, extracellular matrix; RUNX1, runt-related transcription factor 1; siRUNX1, siRNA targeting RUNX1; SSc, systemic sclerosis; TGF- β , transforming growth factor- β ; UMAP, uniform manifold approximation and projection.
Article Snippet: We then analysed a previously generated DNA microarray dataset (National Center for Biotechnology Information Gene Expression Omnibus (NCBI GEO): GSE12493 ) consisting of 2 independent SSc fibroblast cell lines, 1 healthy control fibroblast cell line (isolated in parallel), and 1 normal
Techniques: Expressing, Inhibition, Western Blot, Isolation, Control, Single Cell, RNA Sequencing, Marker
Journal: Annals of the rheumatic diseases
Article Title: RUNX1 is expressed in a subpopulation of dermal fibroblasts and is associated with disease severity of systemic sclerosis
doi: 10.1016/j.ard.2025.10.033
Figure Lengend Snippet: RUNX1 contributes to fibroblast activation, proliferation and contraction. (A) RUNX1 western blot of CRISPR-generated RUNX1 KO and wild-type (WT) fibroblasts under the TGF- β 1 stimulation vs control. RUNX1 isoforms of a, b, and c were marked in the blot by arrows. (B) α -SMA and RUNX1 IF staining of KO and WT fibroblasts under the TGF- β 1 stimulation vs control. (C) α -SMA western blot of KO and WT fibroblasts under the TGF- β 1 stimulation vs control. (D) ACTA2 mRNA expression of KO and WT fibroblasts under the TGF- β 1 induction vs control. (E) Fold change expression of FN1, COL1A1, LUM , and SFRP4 in TGF- β 1-induced SSc fibroblasts treated with Ro5–3335 compared to control (3 lines of SSc fibroblasts, 2 replicates each). (F) Proliferation curve of normal human dermal (NHD) fibroblasts in the presence and absence of Ro5–3335. (G,H) The 3D collagen contraction assays, fixed (G) and floating (H) models, of NHD fibroblasts treated with Ro5–3335 (4 replicates for each condition). SIS3 (SMAD3 inhibitor) was used as positive control that significantly eliminates the contraction ability of fibroblasts. Negative control is collagen matrix with no fibroblasts. The overhead pictures represent 1 replicate for each condition. (I) 3D self-assembled (SA) tissue constructs from the healthy- and SSc-isolated fibroblast lines with donors’ clinical characteristics. H&E staining of representative untreated and Ro5–3335-treated tissues. (J) Tissue area fold change of each cell line over the control for healthy and SSc SA tissues. Data from 3 healthy and 4 SSc lines, 3 replicates per line, repeated in 2 independent sets. (K) Change in area of an SSc-isolated SA tissue when treated for 1, 2, or 3 weeks with Ro5–3335 compared to control (Student’s t test P value: **.001-.01, ****<.0001 in GraphPad Prism v9). α -SMA, alpha smooth muscle actin; H&E, haematoxylin and eosin; KO, knockout; RUNX1, runt-related transcription factor 1; SSc, systemic sclerosis; TGF- β , transforming growth factor- β ;Clustered Regularly Interspaced Palindromic Repeats (CRISPR),Smad Family Member 3 (SMAD3),Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH), Not Applicable (N/A), Quantitative Polymerase Chain Reaction (QPCR), Quantitative Polymerase Chain Reaction, Immunofluorescenc (IF).
Article Snippet: We then analysed a previously generated DNA microarray dataset (National Center for Biotechnology Information Gene Expression Omnibus (NCBI GEO): GSE12493 ) consisting of 2 independent SSc fibroblast cell lines, 1 healthy control fibroblast cell line (isolated in parallel), and 1 normal
Techniques: Activation Assay, Western Blot, CRISPR, Generated, Control, Staining, Expressing, Positive Control, Negative Control, Construct, Isolation, Knock-Out, Real-time Polymerase Chain Reaction
Journal: International Journal of Molecular Sciences
Article Title: Interaction of New-Developed TiO 2 -Based Photocatalytic Nanoparticles with Pathogenic Microorganisms and Human Dermal and Pulmonary Fibroblasts
doi: 10.3390/ijms18020249
Figure Lengend Snippet: Biocompatibility of different concentrations (μg/mL) of the two TiO 2 NPs samples: TiO 2 -1% Fe–N NPs co-precipitated at pH 8.5 (HT1) or pH 5.5 (HT2), as shown by cell viability, lactate dehydrogenase (LDH), and nitric oxide (NO) release assays after 24 and 72 h exposure on normal skin ( a , c , e ) and lung ( b , d , f ) fibroblasts. Results are expressed as the mean ± standard deviation (SD) ( n = 3) and represented relative to the untreated cells (control). * p < 0.05 and ** p < 0.01 compared to control.
Article Snippet:
Techniques: Standard Deviation, Control
Journal: International Journal of Molecular Sciences
Article Title: Interaction of New-Developed TiO 2 -Based Photocatalytic Nanoparticles with Pathogenic Microorganisms and Human Dermal and Pulmonary Fibroblasts
doi: 10.3390/ijms18020249
Figure Lengend Snippet: Relative levels of catalase specific activity in normal skin ( a ) and lung ( b ) fibroblasts exposed to different concentrations (31.25, 62.5 and 125 μg/mL) of TiO 2 -1% Fe–N NPs co-precipitated at pH 8.5 (HT1) or 5.5 (HT2) for 24 and 72 h. Results are expressed as the mean ± standard deviation (SD) ( n = 3) and represented relative to the untreated cells (control). * p < 0.05 and ** p < 0.01 compared to control.
Article Snippet:
Techniques: Activity Assay, Standard Deviation, Control
Journal: International Journal of Molecular Sciences
Article Title: Interaction of New-Developed TiO 2 -Based Photocatalytic Nanoparticles with Pathogenic Microorganisms and Human Dermal and Pulmonary Fibroblasts
doi: 10.3390/ijms18020249
Figure Lengend Snippet: Glutathione-dependent enzymes’ activities and glutathione level in normal skin ( a , c , e ) and lung ( b , d , f ) fibroblasts exposed to different concentrations (31.25, 62.5 and 125 μg/mL) of TiO 2 -1% Fe–N NPs co-precipitated at pH 8.5 (HT1) or 5.5 (HT2) for 24 and 72 h. Results are expressed as the mean ± standard deviation (SD) ( n = 3) and represented relative to the untreated cells (control). * p < 0.05, ** p < 0.01 and *** p < 0.001 compared to control.
Article Snippet:
Techniques: Standard Deviation, Control
Journal: International Journal of Molecular Sciences
Article Title: Interaction of New-Developed TiO 2 -Based Photocatalytic Nanoparticles with Pathogenic Microorganisms and Human Dermal and Pulmonary Fibroblasts
doi: 10.3390/ijms18020249
Figure Lengend Snippet: Malondialdehyde (MDA) levels in normal skin ( a ); and lung ( b ) fibroblasts exposed to different concentrations (31.25, 62.5, and 125 μg/mL) of TiO 2 -1% Fe–N NPs co-precipitated at pH 8.5 (HT1) or 5.5 (HT2) for 24 and 72 h. Results are expressed as the mean ± standard deviation (SD) ( n = 3) and represented relative to the untreated cells (control). * p < 0.05 and ** p < 0.01 compared to control.
Article Snippet:
Techniques: Standard Deviation, Control
Journal: International Journal of Molecular Sciences
Article Title: Interaction of New-Developed TiO 2 -Based Photocatalytic Nanoparticles with Pathogenic Microorganisms and Human Dermal and Pulmonary Fibroblasts
doi: 10.3390/ijms18020249
Figure Lengend Snippet: Actin cytoskeleton organization of skin ( a ); and lung ( b ) fibroblasts after 24 and 72 h of incubation with different concentrations (μg/mL) of the two TiO 2 NPs samples: TiO 2 -1% Fe–N co-precipitated at pH 8.5 (HT1) or pH 5.5 (HT2). F-actin (green) was labeled with phalloidin-fluorescein isothiocyanate (FITC). Scale bar: 100 μm.
Article Snippet:
Techniques: Incubation, Labeling
Journal: Cell reports
Article Title: TACC3 Regulates Microtubule Plus-End Dynamics and Cargo Transport in Interphase Cells
doi: 10.1016/j.celrep.2019.12.025
Figure Lengend Snippet: (A) NHDFs or SK-N-SHs treated with non-targeting (ctrl), EB1, or CLIP-170 (CLIP) siRNAs were mock-infected or infected with HSV-1 at MOI 10 for 5 h and analyzed by WB. (B) SK-N-SHs treated with the indicated siRNAs were infected, as in (A). (C) SK-N-SHs treated with independent EB2 siRNAs (I or II) were infected, as in (A). (D) SK-N-SHs were treated with 100 nM BafA or DMSO and infected at MOI 10 with VSV for 4 h or HSV-1 for 5 h. (E) NHDFs or SK-N-SHs analyzed by WB using the indicated antibodies. (F) NHDFs or SK-N-SHs stained for tyrosinated (Tyr), detyrosinated (Detyr), and acetylated (Ac) tubulin. Nuclei were stained with Hoechst. (G) NHDFs or SK-N-SHs treated with 500 nM DMSO or 10 μM nocodazole were infected at MOI 20 with HSV-1 for 4 h in the presence of 1 μg/mL actinomycin D. Fixed cells were stained for VP5 and with Hoechst. Assessed for the accumulation of VP5 over 2 biological replicates were ≥ 165 NHDF or ≥ 190 SK-N-SH nuclei; error bars, SEMs; *p < 0.05, **p < 0.01, N.S., not significant; unpaired 2-tailed t test. (H) Cells treated as in (G) were infected at MOI 10 with HSV-1 for 5 h. All of the experiments represent ≥3 replicates unless indicated. See also and .
Article Snippet:
Techniques: Infection, Staining
Journal: Cell reports
Article Title: TACC3 Regulates Microtubule Plus-End Dynamics and Cargo Transport in Interphase Cells
doi: 10.1016/j.celrep.2019.12.025
Figure Lengend Snippet:
Article Snippet:
Techniques: Western Blot, Virus, Retroviral, Plasmid Preparation, Recombinant, Transfection, Negative Control, Amplification, Software, Microscopy